Who are we?

Who We Are
  • Background
    close

    We offer a full service for phase 1 and early phase 2 trials. Functions that our competitors outsource, such as laboratory services, pharmacy and endoscopy, are done in-house. Our independence from third parties ensures that all elements of your trial receive the attention they deserve, and meet our high standards. Yet, we're close to the ITU and CCU of an NHS hospital.

    Hammersmith Medicines Research Our sponsors benefit from:

    • 145 beds in a purpose-designed building, close to an NHS hospital
    • the wide range of trials that we can do, as shown by our extensive publications
    • the experience of our 200 staff: 40% have 5-20 years' experience
      at HMR
    • our highly automated on-site laboratory, with rapid turnaround
      and wide range of tests
    • our industry-leading pharmacy, with its sterile production units
      for non-radioactive and radioactive materials
    • our experienced and efficient data management and statistics team

    Hammersmith Medicines Research

    Our reputation for high-quality trials completed on schedule is what keeps sponsors coming back to us. We've maintained high quality work by building up services over 20 years - we haven't become too big, too quickly.

    close
  • Our work
    close

    We've successfully completed over 650 early-phase trials since 1993, so our experience is hard to beat. Many of our trials are demanding, difficult to recruit for, or have complex elements and procedures beyond the capabilities of other CROs.

    Hammersmith Medicines Research

    Hammersmith Medicines Research

    We do 30–40 trials each year, comprising:

    • 33% first-administration-to-man
    • 90% healthy volunteers
    • 10% patients, such as:
      • asthma
      • hayfever
      • COPD
      • benign prostatic hypertrophy
      • diabetes
      • migraine
      • genital warts/herpes

    pie graphic

    Types of study 2005–2009 (n=109*)
    * 35% = FTIM

    Read more about the types of study we do.

    close
  • Our sponsors
    close

    Easy transport links to Heathrow make us a convenient choice for sponsors world-wide. Our international business has won us two Queen's Awards. Our relationships with some sponsors have grown over 20 years. We put great effort into nurturing new sponsors, whether big or small.

     

    Hammersmith Medicines Research

     

    Sources of HMR trials, 1993–2013 (n=620)

    HMR is unique among CROs: if you call us about a potential trial, your enquiry will go directly to our Medical Director, Principal Investigators and Clinical Project Managers – the people who know all about clinical trials and would be intimately involved with yours. So, when you pick up the phone, you’ll speak to someone who understands your needs, and can offer advice based on long experience.

    close
  • Our awards
    close

    Hammersmith Medicines Research

    1994

    Grant from UK Department of Trade and Industry

    1995

    Rubicon Award - New Business of the Year

    1998

    Queen's Award for Export Achievement

    1999

    Rubicon Award - Growing Business of the Year

    1999

    ISO 9001:1994 certification (currently ISO 9001:2008)

    1999

    Fast Track 100 (100 fastest growing UK companies)

    2002

    Queen's Award for Enterprise: International Trade

    2003

    Registration by the Royal Pharmaceutical Society

    2004

    National Training Award

    2004

    Manufacturer's Authorisation for IMP

    2008

    MHRA Phase 1 Supplementary Accreditation

    2010

    CIR accreditation

    2013

    Federalwide Assurance (FWA)

    close
  • HMR timeline
    close

    1993 - 4 beds in St Bartholomew’s Hospital, London

    1994 - 24 beds in Central Middlesex Hospital, NW London

    1996 - 48 beds

    1996 - Data management and statistics

    1999 - ISO9000 accreditation

    2002 - 70 beds

    2002 - Bridging trials - Japanese

    2002 - Central laboratory - ISO9001- & GCLP-compliant

    2003 - Royal Pharmaceutical Society accredited pharmacy

    2004 - MHRA Manufacturer’s Authorisation for IMP

    2008 - MHRA Phase 1 Supplementary Accreditation

    2009 - 100 beds in purpose-designed clinical pharmacology unit

    2009 - Kitchen and in-house catering service

    2009 - Radiopharmacy

    2010 - Endoscopy unit

    2010 - Sleep unit - now 8 beds

    2013 - 145 beds - HMR becomes one of the largest phase 1 units in Europe

    close
  • Central Middlesex Hospital
    close

    HMR is just 500 m from the ambulance entrance to Central Middlesex Hospital (CMH). CMH offers the acute services of a 21st century, 250-bed district hospital. We have had close ties with CMH for over 20 years.

    • 2½ min away from HMR
    • 250-bed District General Hospital
    • Acute services – UCC, ITU and CCU
    • Clinical attachment of HMR physicians to ITU


    Hammersmith Medicines ResearchHammersmith Medicines Research

    close
  • back to top